Trial Profile
A Cross-Sectional Study Investigating the Safety of Deferasirox on Kidney Function in Diabetic and Nondiabetic [beta]-Thalassemia Major Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Sep 2017
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Iron overload
- Focus Adverse reactions
- 20 Sep 2017 New trial record